Results 121 to 130 of about 48,653 (304)
Deep Brain Stimulation and Pregnancy: A Case Report and Literature Review
Movement Disorders Clinical Practice, EarlyView.
Verónica Cabreira, Maria José Rosas
wiley +1 more source
, 1994 A case of fluoxetine induced dyskinesia in an elderly woman with previous use of low dose haloperidol is described. In contrast to neuroleptic induced tardive dyskinesia it was characterised by a rapid onset after commencing fluoxetine and rapid ...
B. Workman +4 more
core +1 more source
MedicinaPrimary ciliary dyskinesia (PCD) is a rare genetic disorder that affects the structure and function of cilia, primarily impacting the respiratory system.
Kacper Packi +4 more
doaj +1 more source
Refractory Motor Complications: Towards a Pragmatic Definition
Movement Disorders Clinical Practice, EarlyView.
Georg Ebersbach, Tobias Warnecke
wiley +1 more source
Tetrabenazine for the Treatment of Tardive Dyskinesia
, 2011 Objective: To evaluate the safety and effectiveness of tetrabenazine for the treatment of tardive dyskinesia. Data Sources: Literature was accessed through MEDLINE (1966-September 2010) and The Cochrane Library using the terms tetrabenazine, tardive ...
Jonathan G Leung, Ericka L Breden
core +1 more source
Factors Associated with Early Discontinuation of Foslevodopa/Foscarbidopa in Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Keita Kakuda +7 more
wiley +1 more source
Effect of bilateral subthalamic deep brain stimulation on diphasic dyskinesia
, 2008 OBJECTIVES: The goal of this study was to assess the effect of bilateral subthalamic deep brain stimulation (STN DBS) on levodopa-induced diphasic dyskinesia in patients with Parkinson disease (PD).
Lee, Jee-Young +5 more
core +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz +2 more
wiley +1 more source
Methylphenidate, Neuroleptics and Dyskinesia-Dystonia
, 1980 Methlyphenidate is one of two stimulant drugs used in the management of the Hyperkinetic Reaction in children. It has been known to have side effects such as dyskinesia, but this case details the emergence of dystonia and dyskinesia when the ...
James Chapel +2 more
core +1 more source
Diurnal‐Only Foslevodopa/Foscarbidopa
Movement Disorders Clinical Practice, EarlyView.
Alexandra McGuckin +3 more
wiley +1 more source